Crispr Therapeutics AG
Biotechnology
Healthcare
CRSP
87.07 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
61.63
52 week high
68.14
high
63.63
52 week low
0.00
previous Close
62.10
P/E ratio
-25
market cap
4.82 B
div yield
0
net incoming
-208.55 M
-53.35 %
net profit margin
-23379.93 %
-7657.00 %
operating incoming
-133.07 M
10.34 %
net change in cash
-41.57 M
34.10 %
cash on hand
197 M
-16.18 %
cost of revenue
49.75 M
-13.49 %
top